Vnitr Lek 2016, 62(Suppl 3):131-134

Congenital Adrenal Hyperplasia in Adults

Jana Vrbíková
Endokrinologický ústav, Praha

Congenital adrenal hyperplasia is a life-long disease requiring an integrated therapy. It may negatively influence the quality of life. In childhood, the main problems of the care of these patients involve sex determination and ensuring optimum growth and puberty. The therapeutic goals for adults are the prevention of Addisonian crisis and ensuring the best possible quality of life, including fertility.

Keywords: androgens; cardiovascular risk; congenital adrenal hyperplasia; bone density; testicular rest tumors

Received: August 10, 2016; Accepted: September 5, 2016; Published: June 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vrbíková J. Congenital Adrenal Hyperplasia in Adults. Vnitr Lek. 2016;62(Supplementum 3):131-134.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ogilvie CM, Crouch NS, Rumsby G et al. Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues. Clin Endocrinol (Oxf) 2006; 64(1): 2-11. Go to original source... Go to PubMed...
    2. Speiser PW, Azziz R, Baskin LS et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95(9): 4133-4160. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2009-2631>. Go to original source... Go to PubMed...
    3. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005; 365(9477): 2125-2136. Go to original source... Go to PubMed...
    4. Debono M, Mallappa A, Gounden V et al. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers. Eur J Endocrinol 2015; 173(6): 727-737. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-15-0064>. Go to original source... Go to PubMed...
    5. King JA, Wisniewski AB, Bankowski BJ et al. Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 2006; 91(3): 865-869. Go to original source... Go to PubMed...
    6. Jaaskelainen J, Voutilainen R. Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 1996; 45(6): 707-713. Go to original source... Go to PubMed...
    7. Guo CY, Weetman AP, Eastell R. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 1996; 45(5): 535-541. Go to original source... Go to PubMed...
    8. Arlt W, Willis DS, Wild SH et al. Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients. J Clin Endocrinol Metab 2010; 95(11): 5110-5121. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2010-0917>. Go to original source... Go to PubMed...
    9. Christiansen P, Molgaard C, Muller J. Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 2004; 61(3): 133-136. Go to original source... Go to PubMed...
    10. Kim MS, Merke DP. Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Semin Reprod Med 2009; 27(4): 316-321. Dostupné z DOI: <http://dx.doi.org/10.1055/s-0029-1225259>. Go to original source... Go to PubMed...
    11. Falhammar H, Filipsson H, Holmdahl G et al. Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2007; 92(1): 110-116. Go to original source... Go to PubMed...
    12. Gastaud F, Bouvattier C, Duranteau L et al. Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 2007; 92(4): 1391-1396. Go to original source... Go to PubMed...
    13. Bidet M, Bellanne-Chantelot C, Galand-Portier MB et al. Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010; 95(3): 1182-1190. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2009-1383>. Go to original source... Go to PubMed...
    14. Lo JC, Grumbach MM. Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30(1): 207-229. Go to original source... Go to PubMed...
    15. Lekarev O, Lin-Su K, Vogiatzi MG. Infertility and Reproductive Function in Patients with Congenital Adrenal Hyperplasia: Pathophysiology, Advances in Management, and Recent Outcomes. Endocrinol Metab Clin North Am 2015; 44(4): 705-722. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ecl.2015.07.009>. Go to original source... Go to PubMed...
    16. Hagenfeldt K, Janson PO, Holmdahl G et al. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 2008; 23(7): 1607-1613. Dostupné z DOI: <http://dx.doi.org/10.1093/humrep/den118>. Go to original source... Go to PubMed...
    17. Bouvattier C, Esterle L, Renoult-Pierre P et al. Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey. J Clin Endocrinol Metab 2015; 100(6): 2303-2313. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014-4124>. Go to original source... Go to PubMed...
    18. Falhammar H, Nystrom HF, Ekstrom U et al. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur J Endocrinol 2012; 166(3): 441-449. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-11-0828>. Go to original source... Go to PubMed...
    19. Falhammar H, Frisen L, Hirschberg AL et al. Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study. J Clin Endocrinol Metab 2015; 100(9): 3520-3528. Dostupné z DOI: <http://dx.doi.org/10.1210/JC.2015-2093>. Go to original source... Go to PubMed...
    20. Allolio B. Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol 2015; 172(3): R115-R124. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-14-0824>. Go to original source... Go to PubMed...
    21. Claahsen-van der Grinten HL, Stikkelbroeck NM, Otten BJ et al. Congenital adrenal hyperplasia - pharmacologic interventions from the prenatal phase to adult hood. Pharmacol Ther 2011; 132(1): 1-14. Dostupné z DOI: <http://dx.doi.org/10.1016/j.pharmthera.2011.05.004>. Go to original source... Go to PubMed...
    22. Mallappa A, Sinaii N, Kumar P et al. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2015; 100(3): 1137-1145. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014-3809>. Go to original source... Go to PubMed...
    23. New MI. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006; 91(11): 4205-4214. Go to original source... Go to PubMed...
    24. Witchel SF, Azziz R. Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010; 2010: 625105. Dostupné z DOI: <http://dx.doi.org/10.1155/2010/625105> Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.